Kidney Transplant News and Research

RSS
A kidney transplant is an operation where a healthy kidney from one person (the donor) is transferred to a person who has little or no kidney function (the recipient).
HealthGrades identifies top-rated hospital organ-transplantation centers

HealthGrades identifies top-rated hospital organ-transplantation centers

Physicians and researchers to develop kidney replacement device for children

Physicians and researchers to develop kidney replacement device for children

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

Lupus patients rarely develop kidney disorders after a kidney transplant

Lupus patients rarely develop kidney disorders after a kidney transplant

Race of kidney donors may affect the survival rates of transplant recipients

Race of kidney donors may affect the survival rates of transplant recipients

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

Pre-dialysis recipients with high kidney function do not benefit from kidney transplants

Pre-dialysis recipients with high kidney function do not benefit from kidney transplants

Group education is an effective way to help alleviate organ shortage and increase living donations

Group education is an effective way to help alleviate organ shortage and increase living donations

Reading levels of kidney transplant consent forms can make it difficult for patients to make informed decisions

Reading levels of kidney transplant consent forms can make it difficult for patients to make informed decisions

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

Less expensive anti-rejection drug as effective as more expensive drug, says study

Less expensive anti-rejection drug as effective as more expensive drug, says study

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

Thomson Reuters's NeoFax deployed at the University of Kansas Hospital for electronic neonatal drug dosing

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.